Recombinant Human RBKS Protein，His

RBKS, or ribonucleoside-triphosphate reductase subunit M2, is a crucial enzyme involved in the de novo synthesis of deoxyribonucleotides, which are essential for DNA replication and repair. The enzyme catalyzes the reduction of ribonucleoside diphosphates to their corresponding deoxyribonucleotides, thereby providing the necessary building blocks for DNA synthesis. Research on RBKS has gained significant attention due to its pivotal role in cellular proliferation and the maintenance of genomic stability. Dysregulation of RBKS activity is linked to various cancer types, where it contributes to the malignancy by supporting uncontrolled cell division. Understanding the structure and function of RBKS can provide insights into its mechanism of action and facilitate the development of targeted therapies for cancers associated with its overexpression or mutation. Recent studies have focused on the characterization of its enzymatic properties, regulatory mechanisms, and interactions with other cellular components, aiming to elucidate its role in pathophysiological processes. The integration of advanced techniques such as structural biology, molecular dynamics simulations, and high-throughput screening has opened new avenues for exploring pharmacological inhibitors and modulators of RBKS, potentially leading to novel cancer treatments. Overall, the research on RBKS is critical not only for basic biological understanding but also for its therapeutic implications in oncology.